Current status and recent progress of second-line drugs for autoimmune hepatitis

Current status and recent progress of second-line drugs for autoimmune hepatitis

Autoimmune hepatitis (AIH) is an immune-mediated liver parenchymal inflammation with hepatocytes as target cells. Second-line drugs can be used for patients who have suboptimal response or intolerance to the standard treatment of AIH. This article reviews the research advances in second-line drugs f...

Full description

Bibliographic Details
Main Author: HU Zhichao
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2018-05-01
Series:Linchuang Gandanbing Zazhi
Subjects:
hepatitis
autoimmune
drug therapy
review
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=9075

Similar Items

Similar Items